Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

To see complete record on, please visit this link

Id: NCT02289248

Organisation Name: Yale University

Overal Status: Completed

Start Date: February 2015

Last Update: March 1, 2017

Lead Sponsor: Yale University

Brief Summary: Subjects with depressive episodes will be recruited to undergo a brief 2 week course of IV infusions of ketamine in combination with cognitive behavioral therapy for 8 weeks.

  • Depression

Total execution time in seconds: 0.28720498085022